MERS-CoV RBD-mRNA vaccine induces potent and broadly neutralizing antibodies with protection against MERS-CoV infection. [PDF]
Virus Res, 2023 Tai W +8 more
europepmc +1 more source
Combination therapy enhances the antiviral activity of IFN-λ against SARS-CoV-2 and MERS-CoV. [PDF]
Virus ResZadeh VR +5 more
europepmc +1 more source
Mers-CoV: From camels to humans [PDF]
International Journal of Infectious Diseases, 2016 openaire +2 more sources
A 10 Year Long-Lived Cellular and Humoral MERS-CoV Immunity Cross-Recognizing the Wild-Type and Variants of SARS-CoV-2: A Potential One-Way MERS-CoV Cross-Protection Toward a Pan-Coronavirus Vaccine. [PDF]
J Med VirolAlosaimi B +9 more
europepmc +1 more source
Design of an Epitope-Based Vaccine Against MERS-CoV. [PDF]
Medicina (Kaunas)Almanaa TN.
europepmc +1 more source
Glycosylated Receptor-Binding-Domain-Targeting Mucosal Vaccines Protect Against SARS-CoV-2 Omicron and MERS-CoV. [PDF]
Vaccines (Basel)Guan X +6 more
europepmc +1 more source
A MERS-CoV antibody neutralizes a pre-emerging group 2c bat coronavirus. [PDF]
Sci Transl Med, 2023 Tse LV +17 more
europepmc +1 more source
Perturbation of <i>de novo</i> lipogenesis hinders MERS-CoV assembly and release, but not the biogenesis of viral replication organelles. [PDF]
J VirolSoultsioti M +6 more
europepmc +1 more source
The role of DC-SIGN as a trans-receptor in infection by MERS-CoV. [PDF]
Front Cell Infect Microbiol, 2023 Labiod N +4 more
europepmc +1 more source
Machine Learning-Guided Screening and Molecular Docking for Proposing Naturally Derived Drug Candidates Against MERS-CoV 3CL Protease. [PDF]
Int J Mol SciOuassaf M +4 more
europepmc +1 more source